Ask AI
FORTITUDE-101
FORTITUDE-101: Bemarituzumab + mFOLFOX6 vs Placebo + mFOLFOX6 in Patients With Advanced/Metastatic FGFR2b  -Overexpressing G/GEJ Cancer

Released: November 03, 2025

Activity

Progress
1
Course Completed
Activity Information

Released: November 03, 2025